Program of Events
- Poster Viewing*
- Keynote Address
- Oral and Poster Sessions
- Awards and Closing Ceremony
*Poster set up will start at 10 am Wednesday, November 30th, and continue through 10 am Thursday, December 1. All posters must be set up in the designated area by 10 am December 1.
Important Dates and Deadlines
- Sep 21 - Registration and abstract submission opens
- Oct 24 - Abstract submission deadline
- Oct 31 - Notification of oral and poster presentations
- Dec 1 - 2022 Research Symposium
Celebrating research: The DMU Research Symposium
The annual Research Symposium is a forum for student and faculty scholars to present what they have learned and discovered through their research experiences and to engage the larger community in discussion on cutting-edge health topics.
The event allows us to celebrate the success of student and faculty scholars whose work demonstrates the critical role research plays in the advancement of health care and the production of new hypotheses.
DMU faculty, staff, students, residents, alumni, external researchers, health professionals, and members of the medical and scientific community in the region are invited to participate and present at the event.
This year, the symposium is in-person and includes oral and poster presentation sessions, a keynote speaker, and an award ceremony.
Contact the Office of Research at email@example.com.
Nanovaccine Platform Technology: A New Paradigm
Balaji Narasimhan, PhD
Anson Marston Distinguished Professor and Vlasta Klima Balloun Faculty Chair
Director, Nanovaccine InstituteDepartment of Chemical and Biological Engineering
Iowa State University
Balaji Narasimhan is an Anson Marston Distinguished Professor and the Vlasta Klima Balloun Faculty Chair in Chemical and Biological Engineering at Iowa State University. He directs the Nanovaccine Institute, an interdisciplinary consortium of universities, national laboratories, research institutes, companies, and hospitals that is focused on the design and development of next-generation nanovaccines and nanotherapeutics. He is a co-founder of a startup called ImmunoNanoMed Inc.
Narasimhan’s lab studies the molecular design of biomaterials-based nanovaccines and nanomedicines against infectious diseases, cancer, and neural disorders. His research has received funding from NIH, NSF, DOD, USDA, VA, Gates, Whitaker, Carver, Keck, and Dreyfus Foundations, and industry. He has co-authored over 300 refereed articles, co-invented ten patents, edited three textbooks, and delivered over 400 invited and contributed lectures.
His awards include: the Society of Biomaterials Clemson Award for Contributions to the Literature; the Whitaker Foundation Biomedical Engineering Research Award; the 3M Non-Tenured Faculty Award; and the TR-100 Award. He is an elected Fellow of AAAS, AIChE, AIMBE, IAMBE, and NAI. He is an Associate Editor of Science Advances.
He received a B. Tech. from IIT Bombay and a Ph.D. from Purdue University, both in Chemical Engineering, and completed postdoctoral work at MIT.